Key result
Simultaneous mitral repair shows no benefit over isolated VSD closure for MR ≥2+ in infants.
Why the study?
The clinical utility of simultaneous mitral valve repair in infants with ventricular septal defect combined with mitral regurgitation was unclear.
Does simultaneous mitral valve repair improve mitral valve function in infants with ventricular septal defect combined with mitral regurgitation?
Cohort (n=46)
Does simultaneous mitral valve repair improve mitral valve function in infants with ventricular septal defect combined with mitral regurgitation?
Answers are grounded in this paper and cite their sources.
Simultaneous mitral valve repair provides no mid-term advantage over isolated VSD closure for mitral valve function in infants with VSD and mitral regurgitation.
OBJECTIVES: This study aimed to assess mitral valve function after repair of ventricular septal defect (VSD) combined with mitral regurgitation (MR) in the mid-term follow-up period, to evaluate the clinical utility of simultaneous mitral valve repair (MVR). METHODS: From June 2005 to March 2014, 60 patients with VSD and MR underwent surgical treatment. After performing propensity score analysis (1:1) for the entire sample, 46 patients were selected and divided into 2 groups: those with VSD closure and MVR (VSD + MVR, 23 patients) and those with VSD closure without mitral valve intervention (VSD only, 23 patients). The follow-up period ranged from 12 to 48 months (median 32 months; interquartile range 28-40 months). RESULTS: There was no postoperative mortality in either group. There was no significant difference in the duration of the postoperative period between groups (ventilation time, P = 0.49; inotropic support, P = 0.50). Mean cardiopulmonary bypass time and aortic cross-clamping time were significantly longer in the 'VSD + MVR' group (cardiopulmonary bypass, P = 0.023; aortic cross-clamp, P < 0.001). There was no significant difference in regurgitation area (P = 0.30) and MR grade (P = 0.76) between groups postoperatively. There was no significant difference in freedom from MR ≥ 2+ between groups (log-rank test, P = 0.28). In the 'VSD + MVR' group, 12-, 36- and 42-month freedom from MR ≥ 2+ values were 100%, 59 ± 10.4% [95% confidence interval (CI) 36.1-76.2%] and 44 ± 15% (95% CI 15.8-69.7%), respectively, while in the 'VSD only' group, these values were 100%, 54.5 ± 10.6% (95% CI 32-72.3%) and 54.5 ± 10.6% (95% CI 30-72.3%), respectively. The only significant risk factor for recurrent MR ≥ 2+ during the follow-up period was mild residual MR in the early postoperative period (P = 0.037). CONCLUSIONS: In infants with VSD combined with MR, simultaneous MVR has no benefits simultaneous MVR provided no advantage over that of isolated VSD closure. We found that the presence of mild residual MR in the early postoperative period predisposes the development of MR ≥ 2+ in follow-up period.
No takes yet. Share an insight, caveat, or question.
Kulyabin et al. (2017) conducted a cohort in Ventricular septal defect combined with mitral regurgitation (n=46). Simultaneous mitral valve repair (VSD + MVR) vs. VSD closure without mitral valve intervention (VSD only) was evaluated on Freedom from MR ≥ 2+ (p=0.28). Simultaneous mitral valve repair provided no significant advantage over isolated VSD closure for freedom from MR ≥2+ in infants with VSD and MR.
Synapse has enriched 10 related papers. Consider them for comparative context: